Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells

Hideaki Karasawa, Koh Miura, Wataru Fujibuchi, Kazuyuki Ishida, Naoyuki Kaneko, Makoto Kinouchi, Mitsunori Okabe, Toshinori Ando, Yukio Murata, Hiroyuki Sasaki, Kazuhiro Takami, Akihiro Yamamura, Chikashi Shibata, Iwao Sasaki

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Currently 5-fluorouracil (5-FU) plays a central role in the chemotherapeutic regimens for colorectal cancers and thus it is important to understand the mechanisms that determine 5-FU sensitivity. The expression profiles of human colon cancer cell line DLD-1, its 5-FU-resistant subclone DLD-1/FU and a futher 21 types of colon cancer cell lines were compared to identify the novel genes defining the sensitivity to 5-FU and to estimate which population of genes is responsible for 5-FU sensitivity. In the hierarchical clustering, DLD-1 and DLD-1/FU were most closely clustered despite over 100 times difference in their 50% inhibitory concentration of 5-FU. In DLD-1/FU, the population of genes differentially expressed compared to DLD-1 was limited to 3.3%, although it ranged from 4.8% to 24.0% in the other 21 cell lines, thus indicating that the difference of 5-FU sensitivity was defined by a limited number of genes. Next, the role of the cellular inhibitor of apoptosis 2 (cIAP2) gene, which was up-regulated in DLD-1/ FU, was investigated for 5-FU resistance using RNA interference. The down-regulation of cIAP2 efficiently enhanced 5-FU sensitivity, the activation of caspase 3/7 and apoptosis under exposure to 5-FU. The immunohistochemistry of cIAP2 in cancer and corresponding normal tissues from colorectal cancer patients in stage III revealed that cIAP2 was more frequently expressed in cancer tissues than in normal tissues, and cIAP2-positive patients had a trend toward early recurrence after fluorouracil-based chemotherapy. Although the association between drug sensitivity and the IAP family in colorectal cancer has not yet been discussed, cIAP2 may therefore play an important role as a target therapy in colorectal cancer.

Original languageEnglish
Pages (from-to)903-913
Number of pages11
JournalCancer science
Volume100
Issue number5
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells'. Together they form a unique fingerprint.

  • Cite this

    Karasawa, H., Miura, K., Fujibuchi, W., Ishida, K., Kaneko, N., Kinouchi, M., Okabe, M., Ando, T., Murata, Y., Sasaki, H., Takami, K., Yamamura, A., Shibata, C., & Sasaki, I. (2009). Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells. Cancer science, 100(5), 903-913. https://doi.org/10.1111/j.1349-7006.2009.01112.x